Comera Life Sciences Holdings, Inc. (CMRA) is a publicly traded company in the Unknown sector. Across all available filings, 12 corporate insiders have executed 37 transactions totaling $3.5M, demonstrating a bullish sentiment with $3.5M in net insider flow. The most recent transaction on Nov 27, 2023 involved a purchase of 10,000 shares valued at $700.
No significant insider buying has been recorded for CMRA in the recent period.
No significant insider selling has been recorded for CMRA in the recent period.
Based on recent SEC filings, insider sentiment for CMRA is bullish with an Insider Alignment Score of 100/100 and a net flow of $3.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Comera Life Sciences Holdings, Inc. (CMRA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 12 insiders are actively trading CMRA stock, having executed 37 transactions in the past 90 days. The most active insider is Charles Cherington (Executive), who has made 10 transactions totaling $2.5M.
Get notified when executives and directors at CMRA file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Nov 27, 2023 | Gerard Campbell Michael | Executive | Purchase | 10,000 | $0.07 | $700 | |
| Nov 15, 2023 | A. Wexler William | Executive | Other | 3,113 | $N/A | $0 | |
| Sep 11, 2023 | Cherington Charles | Executive | Purchase | 2,053,789 | $0.51 | $1.0M | Large |
| Sep 11, 2023 | Soane David | Executive | Purchase | 58,680 | $0.51 | $29.9K | |
| Sep 11, 2023 | Soane David | Executive | Purchase | 58,680 | $0.51 | $29.9K | |
| Aug 14, 2023 | Patrick Mahoney Robert | Executive | Purchase | 20,000 | $0.63 | $12.6K | |
| Aug 11, 2023 | A. Wexler William | Executive | Other | 6,636 | $N/A | $0 | |
| Jul 31, 2023 | Soane David | Executive | Purchase | 136,919 | $0.51 | $69.8K | |
| Jul 31, 2023 | Soane David | Executive | Purchase | 136,919 | $0.51 | $69.8K | |
| Jul 31, 2023 | Cherington Charles | Executive | Purchase | 880,195 | $0.51 | $448.9K | |
| Jan 4, 2023 | Soane David | Executive | Purchase | 67,567 | $1.23 | $83.1K | |
| Jan 4, 2023 | Soane David | Executive | Purchase | 67,567 | $1.23 | $83.1K | |
| Jan 4, 2023 | Soane David | Executive | Purchase | 67,567 | $1.23 | $83.1K | |
| Jan 4, 2023 | Flowers Kirsten | Executive | Award | 13,513 | $1.23 | $16.6K | |
| Jan 4, 2023 | Aloysius Sullivan Edward Jr | Executive | Award | 10,979 | $1.23 | $13.5K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 29 | $3.5M | 94.4% |
Award(A) | 6 | $204.6K | 5.6% |
Other(J) | 2 | $0 | 0.0% |
Insiders at Comera Life Sciences Holdings, Inc. are accumulating shares at an accelerated pace. With 12 insiders making 37 transactions totaling $3.5M in purchases versus $0 in sales, the net buying activity of $3.5M signals strong executive confidence. Charles Cherington (Executive) leads the buying activity with $2.5M in transactions across all time.